
Morepen Labs’ Q4 net profit declines 29 pc as rising expenses weigh on margins
Mumbai, May 12 (IANS) Pharmaceuticals company Morepen Labs on Monday reported a decline of 29.3 per cent in its net profit (year-on-year) for the fourth quarter (Q4) of FY25, as rising expenses took a toll on the healthcare company's performance.The net profit for Q4 stood at Rs 20.3 crore, down from Rs 28.7 crore in the same period last fiscal, according to its stock exchange filing.The company’s total revenue increased by 10.1 per cent, reaching Rs 465.8 crore in Q4, compared to Rs 423 crore in the year-ago period.Despite this growth in revenue, operating costs surged, which led to a decline in profitability.The company’s earnings before interest, taxes, depreciation, and amortisation (EBITDA) also saw a drop of 12.6 per cent, standing at Rs 42.3 crore for the quarter, compared to Rs 48....